Alcohol use disorder is a major cause of advanced liver disease worldwide. Bataller and colleagues review the epidemiology, pathophysiology, and treatment of alcohol-associated hepatitis including the evidence for steroids and liver transplantation.
I am very grateful to have been able to collaborate in this
@TheLancet
Seminar on Acute Liver Failure with
@MaiwallRakhi
@AnandVKulkarni2
@salvatore_piano
Very important topic, hope you find it useful and informative
👉 Acute liver failure (ALF) is a life-threatening disorder
Our article "MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis"
@JHEP_Reports
✅MELD 3.0 was the best predictor of renal replacement therapy requirements
#LiverTwitter
Now online "Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation" at
@NatRevGastroHep
✅ Discuss pharmacotherapy for AUD in the LT setting
✅ Review behavioral therapies
✅ Propose a definition for relapse
Our paper by
@LuisAntonioDiaz
et al. New insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease!
Now online in
@HEP_Journal
Are you interested in pursuing an
#academic
career in
#Hepatology
?
#LiverTwitter
✅I invite you to apply to our Advanced Hepatology Clinical Research Fellowship at
@WesternU
📩If interested, please email us at hepatology.western
@gmail
.com
I feel fortunate to have had the opportunity of visiting
@Stanford_GI
and delivering Grand Rounds on
#ALD
. Amazing place with even most amazing people. Plus, I was lucky to see 2 of my fav lebaneses after 4 years! I’m taking some sunshine back home with me
#LiverTwitter
Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?
☝️VERY important question
✌️ Especially in those individuals with liver disease
🚨 Limits are probably lower than what we previously thought
Thanks
@mromerogomez
for the
So happy to have the opportunity to present about alcohol-associated liver disease at
#DDW2024
Postgraduate Course
@AmerGastroAssn
@AASLDtweets
Summary:
#ALD
burden is increasing, especially in young and women. We need to screen for AUD and provide support and treatment.
This picture means a lot… seeing friends and mentors in person after so long… thanks
@AASLDtweets
for the amazing ETC conference on
#ALD
!
#LiverTwitter
🚨NEW from
@GlobalAlcHep
🚨
@HEP_Journal
#WinstonDunn
et al. An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study
✅ Harnessing AI within a global consortium, we pioneered a scoring system excelling over
#LiverTwitter
Our article "MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis" in
@JHEP_Reports
is now available online here:
Rivaroxaban improves liver decompensation in cirrhosis
🤔in whom? When to start? Is rivaroxaban the best option in cirrhosis? For how long?
Many questions ❓⁉️
#LiverTwitter
#MASLD
/
#MASH
drugs in the pipeline are many! Promising data in:
✅GLP1 R agonists
✅SGLT2 inhib
✅Those linked to BAs (FXR, FGF19, FGF21, TGR5)
✅… And many more!
Looking forward to what the future will bring
#LiverTwitter
No se pierdan XXVIII Congreso ALEH 2023
29 de agosto hasta el 1 de septiembre
Bogotá, Colombia!! 🇨🇴
@alehlatam
#LiverTwitter
Más info e inscripciones acá 👇👇👇
Ya en Buenos Aires para compartir con los amigos de la
@SAHEpatologia
. No se pierdan el excelente programa que parte mañana con el curso precongreso!
#LiverTwitter
Did you miss the State-of-the-art lecture: "MASLD: New nomenclature and implications for Liver Transplantation" by the extraordinary
@kymwatt
?
No worries! You can see it here:
#LiverTwitter
A perfect cake for an amazing woman 👩, extraordinary doctor 👩⚕️, badass mom 👨👩👦👦, awesome wife 💍 (although she needs a Twitter account 😂)... gifted to her by a nurse.
#MedTwitter
#GITwitter
#LiverTwitter
📢 Our latest review article by Prof. Arab and his colleagues from Western University, Canada, is now live! 🚀Dive into cutting-edge research at the intersection of nephrology and liver transplantation. 📚
👉
@FrontGastro_BMJ
@BMJOpen_Gastro
New Health Policy - Diaz et al - The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas
#NAFLD
#fattyliver
@LuisAntonioDiaz
@ALEH
Thanks
@UAlbertaGI
for the invitation. I was amazed by the stellar group of Academic Hepatologists… such an example! I learned a lot! And brought you some good weather 😎🤣 Many opportunities for collaboration. Thanks and hope to see you all again soon!
#LiverTwitter
#GITwitter
Last week we finished the first Program For Advanced Training Of Hepatologists In Alcohol Use Disorder Management (PRATHAM). Highly recommended to every hepatologist caring for pts with AUD. Thanks to the organizers!
@vknNIMHANS_ECHO
Worldwide study:
Corticosteroids improve 30-day survival among patients with severe alcohol-associated
#hepatitis
, especially with MELD scores between 25 and 39
By
@juanpabloarab
&
@LuisAntonioDiaz
& colleagues➡️
Liver Transplantation in chronic liver disease and acute on chronic liver disease- Indication, Timing and Practices
A comprehensive review by
@ashok_doctor
et al
#LiverTwitter
#Transplant
@rabataller
presenting tips on mentoring
1 Be prepared
2 Personalized
3 Regular follow-up meetings
4 Knowing your mentee
5 Give space
6 Confidence/Flexibility
7 Advocate
8 Learn from your mentee
9 Complete the work on time
10 Independence
#LiverTwitter
@alehlatam
@AASLDtweets
Ahora
@DrJavierCrespo
presentando sobre herramientas diagnosticas no invasivas para evaluar fibrosis e hipertensión portal en MASH
@alehlatam
#ALEH2023
✅GPVH se correlaciona con mortalidad
✅Posibilidad de reversibilidad y recompensación